FLD Q1 2026 Earnings Steep EPS Miss Triggers DoubleDigit Stock Decline Lisata Therapeutics Q3 2025 Earnings NarrowerthanExpected Loss as Biotech Advances Clinical Pipeline Viridian Therapeutics Q1 2026 Earnings NarrowerThanExpected Loss Highlights Progress in Thyroid Eye Disease Pipeline ACGL Q1 2026 Earnings Slight EPS Miss Highlights Strong Underwriting Amid Market Headwinds SYF Q1 2026 Earnings EPS Beat Highlights Resilient Consumer Credit Performance Lee Enterprises LEE Q1 2026 Earnings EPS Beats Estimates by a Wide Margin Stock Slips